Company Profile

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA)
8:00 PM UTC, 05/16/25
Last: $16.94 Change: +0.07 %Change: +0.41% Volume: 9,765,065
Detailed Quote
Open: $ 17.12   Volume: 9,765,065
High: $ 17.22   Yield(%) 0.00
Low: $ 16.75   P/E Ratio (ttm): n/a
Dividend ($): 0.07   Market Cap ($): 19.33B
EPS ($) -1.14   Shares Out: 1.15B
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): 23.59
% Price Change (last 13 weeks): 1.44
% Price Change (last 26 weeks): 0.72
% Price Change (last 52 weeks): 3.50
% Price Change (year to date): -23.46
Management Effectiveness
Return on Equity (%): -25.45
Return on Assets (%): -3.96
Return on Invested Capital (%): -5.33
Profitability
Gross Profit Margin (%): 48.63
Net Profit Margin (%): -9.93
Operating Profit Margin (%): 20.16
Price & Volume
50-day Moving Average: $15.45
200-day Moving Average: $17.54
Avg. Daily Vol. (last 50 days): 12,703,321
Avg. Daily Vol. (last 200 days): 10,335,830
52-wk high: $22.80
52-wk low: $12.46
Bid: $16.71
Ask: $17.01
Company Information
Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International Markets. The United States segment focuses on therapeutic area of central nervous system (CNS) portfolio, and is involved in the distribution business of generic, biosimilar and medicines, and over-the-counter (OTC) pharmaceutical products from the firm and third-party manufacturers to independent retail pharmacies, pharmacy retail chains, hospitals, and physician offices in the United States. The Europe segment offers OTC portfolio including SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brands in European Union, the United Kingdom, and certain other European countries. The International Markets segment provides its products to countries such as Canada, Israel, Russia, Latin America, and Japan. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
Teva Pharmaceutical Industries Ltd.
124 Dvora HaNevi'a Street
Tel Aviv TA 6944020

Phone: 972.3.914.8213
Fax: n/a
http://www.tevapharm.com
Per Share Data
Earnings (1year) ($): -1.14
Annual Dividend ($): 0.00
Current P/E Ratio (ttm): n/a
Book Value ($): 4.74
Cash Flow ($): -0.51
Valuation Ratios
Price/Earnings (x): n/a
Price/Sales (x): 1.51
Price/Book (x): 4.65
Price/Cash Flow (x): 9.82
Financial Strength
Quick Ratio (x): 0.75
Current Ratio (x): 0.98
LT Debt/Equity (x): 303.33
Total Debt/Equity (x): 338.10



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2021 Wall Street Horizon, Inc.